Chair-Bound 12s Shouldn't Cost You Your Health.
You keep everyone else alive. Meanwhile, rotating shifts, forced overtime, and a console you can't leave stack the metabolic deck against you. GLP-1 medications reset the biology — with first-responder pricing extended to dispatchers and telecommunicators.
Why Dispatchers Gain Weight Differently
It isn't discipline. It's biology — the specific biology of chair-bound, rotating, high-stress shift work.
Chair-Bound 12s
Dispatch is one of the most sedentary jobs in public safety. Twelve hours locked to a console, minimal steps, minimal chance to move. Your metabolism runs on movement it isn't getting.
Rotating & Overnight Shifts
Circadian misalignment reduces insulin sensitivity and slows metabolic rate. Rotating between days, evenings, and mids keeps your body permanently out of rhythm — you process calories differently at night.
Stress + Vending-Machine Meals
High-acuity calls spike cortisol; cortisol tells your body to store visceral fat. Combine that with vending-machine snacks, break-room donuts, and takeout on forced OT, and the deck is fully stacked against you.
How GLP-1 Medications Work for Dispatchers
GLP-1 medications work with your body's hormonal systems to reduce appetite and drive lasting weight loss — regardless of whether you're on a straight overnight, a rotating 12, or eight hours of forced OT you didn't see coming.
Slows digestion
Slows gastric emptying so you feel full longer after a meal — even when that meal is a microwaved burrito at 3am between call bursts.
Resets hunger hormones
Corrects the ghrelin and leptin dysregulation caused by rotating shifts and chair-bound overnights — cutting the biological pull toward the vending machine.
Improves metabolism
Improves insulin sensitivity and glucose handling, directly countering the metabolic slowdown that comes with chronic circadian misalignment.
Slows digestion
Slows gastric emptying so you feel full longer after a meal — even when that meal is a microwaved burrito at 3am between call bursts.
Resets hunger hormones
Corrects the ghrelin and leptin dysregulation caused by rotating shifts and chair-bound overnights — cutting the biological pull toward the vending machine.
Improves metabolism
Improves insulin sensitivity and glucose handling, directly countering the metabolic slowdown that comes with chronic circadian misalignment.
Willpower Isn't the Fix.
Biology Is.
Dispatchers face the same hormonal disruption as the responders on the other end of the radio — plus a chair-bound job. Standard diet advice doesn't account for that.
GLP-1 medications correct the underlying hormonal signals, not just the symptoms.
Clinical Evidence
Up to 20.9% average weight loss in SURMOUNT-1 (72 weeks). Dual GLP-1/GIP mechanism.
Jastreboff AM, et al. SURMOUNT-1. N Engl J Med. 2022;387(3):205-216.
14.9–17.4% average weight loss in STEP 1 (68 weeks). Most studied GLP-1 medication.
Wilding JPH, et al. STEP 1. N Engl J Med. 2021;384:989-1002.
Short sleep duration is associated with a 55% increased risk of obesity — a baseline condition for anyone working rotating overnights.
Cappuccio FP, et al. Sleep. 2008;31(5):619-626.
Circadian misalignment reduces insulin sensitivity and impairs metabolic health — independent of what or how much you eat.
Scheer FA, et al. Proc Natl Acad Sci USA. 2009;106(11):4453-4458.
Up to 20.9% average weight loss in SURMOUNT-1 (72 weeks). Dual GLP-1/GIP mechanism.
Jastreboff AM, et al. SURMOUNT-1. N Engl J Med. 2022;387(3):205-216.
14.9–17.4% average weight loss in STEP 1 (68 weeks). Most studied GLP-1 medication.
Wilding JPH, et al. STEP 1. N Engl J Med. 2021;384:989-1002.
Short sleep duration is associated with a 55% increased risk of obesity — a baseline condition for anyone working rotating overnights.
Cappuccio FP, et al. Sleep. 2008;31(5):619-626.
Circadian misalignment reduces insulin sensitivity and impairs metabolic health — independent of what or how much you eat.
Scheer FA, et al. Proc Natl Acad Sci USA. 2009;106(11):4453-4458.
GLP-1 Options for 911 Dispatchers
Tirzepatide
The most effective GLP-1/GIP dual agonist for significant weight loss
- Most effective weight loss medication available
- Dual GLP-1/GIP action for enhanced results
- Up to 20.9% body weight reduction in clinical trials¹
Semaglutide
Proven GLP-1 medication for effective weight management
- Clinically proven 14.9–17.4% weight loss²
- Once-weekly injection
- Reduces hunger and cravings
Tirzepatide
The most effective GLP-1/GIP dual agonist for significant weight loss
- Most effective weight loss medication available
- Dual GLP-1/GIP action for enhanced results
- Up to 20.9% body weight reduction in clinical trials¹
Semaglutide
Proven GLP-1 medication for effective weight management
- Clinically proven 14.9–17.4% weight loss²
- Once-weekly injection
- Reduces hunger and cravings
First-responder pricing extends to 911 dispatchers, call-takers, and telecommunicators — same rate as firefighters, police, and EMS.
Built to Fit Around Your Rotation
No clinic visits. No time-off request. Everything happens on your schedule — between calls, after shift, on your days off.
Frequently Asked Questions
About Our Medications
Our treatments contain active pharmaceutical ingredients that conform to USP (United States Pharmacopeia) monograph standards and are custom-compounded by licensed 503A and 503B pharmacies to meet your individual needs. Compounded medications are not FDA-approved finished drug products. The suggested formulations are provided for reference only and are based on formulations that have historically been prescribed by duly licensed prescribers. All medications are prepared in accordance with a valid prescription from a licensed healthcare provider following a medical consultation.
Medical Consultation Required
Our licensed medical providers will evaluate your health history and goals to determine the most appropriate treatment option for you. Prescriptions are subject to medical evaluation and are not guaranteed. If we are unable to prescribe treatment after your consultation, you pay zero. Independent clinical services provided by: Wasef Health, PC c/o Michael Wasef MD. Licensed in all 50 states + DC.
Clinical References
- 1Jastreboff AM, et al. SURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
- 2Wilding JPH, et al. STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
- 3Cappuccio FP, et al. Meta-Analysis of Short Sleep Duration and Obesity in Children and Adults. Sleep. 2008;31(5):619-626.
- 4Scheer FA, et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009;106(11):4453-4458.